Zetia and Transaminases increased - a phase IV clinical study of FDA data

Summary:

Transaminases increased is reported as a side effect among people who take Zetia (ezetimibe), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Paxil, and have Cystinosis.

The phase IV clinical study analyzes which people have Transaminases increased when taking Zetia. It is created by eHealthMe based on reports of 47,765 people who have side effects when taking Zetia from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Transaminases increased?

Transaminases increased is found to be associated with 1,161 drugs and 1,514 conditions by eHealthMe. Check the latest studies of Transaminases increased.

On Jul, 16, 2026

47,765 people reported to have side effects when taking Zetia.
Among them, 57 people (0.12%) have Transaminases increased.

Could Zetia cause Transaminases increased?

Among these 57 people:

How long have people been on Zetia when they have Transaminases increased? *

What is the gender of people who have Transaminases increased when taking Zetia? *

female: 50 %
male: 50 %

What is the age of people who have Transaminases increased when taking Zetia? *

What are other drugs people take besides Zetia? *

What are other side effects people have besides Transaminases increased? *

Fall: 11 people, 19.30%
Abdominal Pain: 9 people, 15.79%
Broken Bone: 8 people, 14.04%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 8 people, 14.04%
Keratitis Bacterial (inflammation of the cornea due to bacterial infection): 8 people, 14.04%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 14.04%
Nausea And Vomiting: 8 people, 14.04%
Shunt Occlusion (blockage of shunt): 6 people, 10.53%
Ammonia Increased: 6 people, 10.53%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 5 people, 8.77%

What are the existing conditions these people have? *

Diabetes: 8 people, 14.04%
Cystinosis (abnormal accumulation of the amino acid cystine): 8 people, 14.04%
Chronic Kidney Disease: 7 people, 12.28%
Stress And Anxiety: 5 people, 8.77%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 8.77%
Depression: 5 people, 8.77%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 8.77%
Hepatitis B: 3 people, 5.26%
Hiv Infection: 2 people, 3.51%
Dyslipidaemia (abnormal amount of lipids): 2 people, 3.51%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Transaminases increased?

- Check whether Transaminases increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zetia:

Zetia (49,113 reports)

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transaminases increased:

Transaminases increased (1,161 drugs)

Browse all the conditions that are associated with Transaminases increased:

Transaminases increased (1,514 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.